Provided by Tiger Trade Technology Pte. Ltd.

Alvotech

3.53
-0.0500-1.40%
Post-market: 3.530.00000.00%16:10 EDT
Volume:1.26M
Turnover:4.47M
Market Cap:1.10B
PE:14.70
High:3.62
Open:3.57
Low:3.44
Close:3.58
52wk High:11.85
52wk Low:3.42
Shares:313.00M
Float Shares:116.17M
Volume Ratio:2.06
T/O Rate:1.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2402
EPS(LYR):-0.8654
ROE:--
ROA:3.61%
PB:-3.88
PE(LYR):-4.08

Loading ...

Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma

GlobeNewswire
·
Dec 22, 2025

Assessing Alvotech (NasdaqGM:ALVO)’s Valuation After FDA Setback and 2025 Guidance Cut

Simply Wall St.
·
Dec 22, 2025

Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®

GlobeNewswire
·
Dec 19, 2025

BRIEF-Alvotech and Teva Secure U.S. Settlement Date For AVT06

Reuters
·
Dec 19, 2025

Alvotech Sa - License Entry Date for Avt06 in U.S. Set for Q4 2026

THOMSON REUTERS
·
Dec 19, 2025

BRIEF-Alvotech SA Reaffirmed Full Year Outlook For 2025

Reuters
·
Dec 17, 2025

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday as Investors Digest Latest Economic Data

MT Newswires Live
·
Dec 17, 2025

Alvotech Sa - Reaffirmed Full Year Outlook for 2025

THOMSON REUTERS
·
Dec 17, 2025

Alvotech Sa - Anticipates 2026 Total Revenues in the Range of $650-$700 Million

THOMSON REUTERS
·
Dec 17, 2025

Alvotech Sa - 2026 Guidance Takes Into Account Impact of Any Further Delays in Obtaining Certain Marketing Approval From U.S. FDA

THOMSON REUTERS
·
Dec 17, 2025

Alvotech Sa: Co and U.S. Commercial Partner Reached Settlement and License Agreement With Regeneron Pharmaceuticals on Launch of Avt06 in US

THOMSON REUTERS
·
Dec 17, 2025

Alvotech Sa FY2026 Shr View $0.41, REV View $842.2 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
Dec 17, 2025

BRIEF-Alvotech Places $108 Mln Senior Unsecured Convertible Bonds

Reuters
·
Dec 17, 2025

Reg-Alvotech Successfully Places USD 108 Million Senior Unsecured Convertible Bonds in a Significantly Oversubscribed Offering

THOMSON REUTERS
·
Dec 17, 2025

Alvotech SA Launches $100 Million Senior Unsecured Convertible Bond Offering

Reuters
·
Dec 17, 2025

Alvotech Launches $100 Million Senior Unsecured Convertible Bond Offering to Continue Strong Investment in R&D, Support Manufacturing, Global Product Launches and Enhance Liquidity Position, reaffirms 2025 outlook and provides 2026 guidance

GlobeNewswire
·
Dec 17, 2025

Alvotech (NasdaqGM:ALVO) Valuation After FDA Setback, Forecast Cuts And Rising Legal Scrutiny

Simply Wall St.
·
Dec 14, 2025

Alvotech Initiated at Underweight by Barclays

Dow Jones
·
Dec 09, 2025

Nordic Stocks Rise; Alvotech Climbs Highest

Dow Jones
·
Dec 06, 2025

Nordic Stocks Drop; Alvotech Falls Furthest

Dow Jones
·
Dec 04, 2025